Aplaca, Allan .

HRN: 28-62-25  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/24/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/24/2026
03/02/2026
IV
500mg
Q8
Acute Surgical Abdomen
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: